Table 1 Clinico-pathological features of the molecular subtypes of SNU data
From: Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer
 | iCl1 (n = 9) | iCl2 (n = 24) | iCl3 (n = 31) | P value (χ 2-test) |
---|---|---|---|---|
Sex | ||||
 Male | 8 | 19 | 29 | 0.276 |
 Female | 1 | 5 | 2 |  |
Age | ||||
 <60 (years) | 5 | 12 | 16 | 0.960 |
 ≥60 (years) | 4 | 12 | 15 |  |
Stage | ||||
 T1/T2 | 5 | 21 | 27 | 0.065 |
 T3/T4 | 4 | 3 | 4 |  |
Nodal metastasis | ||||
 No | 7 | 24 | 30 | 0.060 |
 Yes | 1 | 0 | 0 |  |
Tumor size | ||||
 <5 cm | 6 | 10 | 12 | 0.319 |
 ≥5 cm | 3 | 14 | 19 |  |
Vascular invasion | ||||
 No | 1 | 15 | 19 | a0.002 |
 Yes | 7 | 16 | 5 |  |
Gross type | ||||
 Simple nodular | 3 | 16 | 14 | 0.110 |
 Multi nodular/infiltrative | 6 | 7 | 16 |  |
AFP | ||||
 <400 (ng/ml) | 5 | 18 | 25 | 0.286 |
 ≥400 (ng/ml) | 4 | 5 | 6 |  |
Grade | ||||
 I, II | 2 | 11 | 19 | 0.278 |
 III, IV | 4 | 5 | 10 |  |